FDA Expands ANDA Prioritization Policy

Drug Industry Daily
A A
Under a new category of generic ANDAs eligible for priority review, the FDA will prioritize applications likely to be ready for approval shortly after the six months of marketing exclusivity that is awarded to a first-to-file generic drug.

To View This Article:

Login

Subscribe To Drug Industry Daily